SLN
Silence Therapeutics plcCompany with tickers: SLN, SLNCF
CIK
1479615
CUSIP
82686Q101
Shares Outstanding
47,234,613
Investor Relations
https://www.silence-therapeutics.com/investors/
13F Activity (30d)
38 filings
37 filers
Quarterly earnings calls grouped as a single event — the transcript, the 8-K earnings release, the quarter's 10-Q or 10-K, and (where available) the audio and slide deck. Each badge shows which artefacts have landed for that quarter.
| Period | Call date | Event | Artefacts | Open |
|---|---|---|---|---|
| FY2024 Q4 | 2024-12-31 | Silence Therapeutics plc Q4 FY2024 Earnings Call |
Audio
Transcript
Slides
8-K
10-K
|
|
| FY2023 Q4 | 2023-12-31 | Silence Therapeutics plc Q4 FY2023 Earnings Call |
Audio
Transcript
Slides
8-K
10-K
|
|
| FY2022 Q4 | 2022-12-31 | Silence Therapeutics plc Q4 FY2022 Earnings Call |
Audio
Transcript
Slides
8-K
10-K
|
|
| FY2021 Q4 | 2021-12-31 | Silence Therapeutics plc Q4 FY2021 Earnings Call |
Audio
Transcript
Slides
8-K
10-K
|
|
| FY2021 Q2 | 2021-06-30 | Silence Therapeutics plc Q2 FY2021 Earnings Call |
Audio
Transcript
Slides
8-K
10-Q
|
|
| FY2020 Q4 | 2020-12-31 | Silence Therapeutics plc Q4 FY2020 Earnings Call |
Audio
Transcript
Slides
8-K
10-K
|
|
| FY2020 Q2 | 2020-06-30 | Silence Therapeutics plc Q2 FY2020 Earnings Call |
Audio
Transcript
Slides
8-K
10-Q
|
Showing 1–7 of 7 earnings calls